UB Paderborn / Katalog / Suche / in CDI

1 – 16 von 16

Sortiert nach

Prognosis of three histological subtypes of colorectal adenocarcinoma: A retrospective analysis of 8005 Chinese patients

Cancer medicine (Malden, MA), 2019-07, Vol.8 (7), p.3411-3419

2019

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA-223 Enhances Radiation Sensitivity of U87MG Cells In Vitro and In Vivo by Targeting Ataxia Telangiectasia Mutated

International journal of radiation oncology, biology, physics, 2014-03, Vol.88 (4), p.955-960

2014

Link zum Volltext

Verfügbarkeit prüfen

An expansion study of genotype-driven weekly irinotecan and capecitabine in combination with neoadjuvant radiotherapy for locally advanced rectal cancer with UGT1A1 11 genotype

Therapeutic advances in gastroenterology, 2019, Vol.12, p.1756284819852293

2019

Link zum Volltext

Verfügbarkeit prüfen

Long-course neoadjuvant chemoradiotherapy with versus without a concomitant boost in locally advanced rectal cancer: a randomized, multicenter, phase II trial (FDRT-002)

Radiation oncology (London, England), 2019-11, Vol.14 (1), p.215-9, Article 215

2019

Link zum Volltext

Verfügbarkeit prüfen

Risk factors of synchronous inguinal lymph nodes metastasis for lower rectal cancer involving the anal canal

PloS one, 2014-11, Vol.9 (11), p.e111770-e111770

2014

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma

Radiation oncology (London, England), 2013-05, Vol.8 (1), p.130-130, Article 130

2013

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients

Radiation oncology (London, England), 2010-12, Vol.5 (1), p.118-118, Article 118

2010

Link zum Volltext

Verfügbarkeit prüfen

Genotype-driven phase I study of weekly irinotecan in combination with capecitabine-based neoadjuvant chemoradiation for locally advanced rectal cancer

Radiotherapy and oncology, 2018-10, Vol.129 (1), p.143-148

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase II clinical trial of advanced and metastatic gastric cancer based on continuous infusion of 5-fluorouracil combined with epirubicin and oxaliplatin

Journal of cancer research and clinical oncology, 2008-09, Vol.134 (9), p.929-936

2008

Link zum Volltext

Verfügbarkeit prüfen

Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study

Radiation oncology (London, England), 2014-03, Vol.9 (1), p.70-70, Article 70

2014

Link zum Volltext

Verfügbarkeit prüfen

Unfavorable effect of small tumor size on cause-specific survival in stage IIA colon cancer, a SEER-based study

International journal of colorectal disease, 2015-01, Vol.30 (1), p.131-137

2015

Link zum Volltext

Verfügbarkeit prüfen

CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer

Radiation oncology (London, England), 2015-02, Vol.10 (1), p.57-57, Article 57

2015

Link zum Volltext

Verfügbarkeit prüfen

Integrated Analysis of Transcriptomic and Proteomics Data Reveals the Induction Effects of Rotenoid Biosynthesis of Mirabilis himalaica Caused by UV-B Radiation

International journal of molecular sciences, 2018-10, Vol.19 (11), p.3324

2018

Link zum Volltext

Verfügbarkeit prüfen

circCPA4 induces malignant behaviors of prostate cancer via miR-491-5p/SHOC2 feedback loop

Clinics (São Paulo, Brazil), 2024-01, Vol.79, p.100314-100314, Article 100314

2024

Link zum Volltext

Verfügbarkeit prüfen

Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation

Oncotarget, 2016-09, Vol.7 (37), p.58995-59005

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(16)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Life Sciences & Biomedicine
(14)
Humans
(12)
Male
(11)
Oncology
(11)
Female
(9)
Adult
(8)
Aged
(8)
Cancer
(8)
Colorectal Cancer
(8)
Middle Aged
(8)
Adenocarcinoma - Pathology
(7)
Cancer Therapies
(7)
Chemotherapy
(7)
Radiology, Nuclear Medicine & Medical Imaging
(7)
Neoplasm Staging
(6)
Rectal Neoplasms - Pathology
(6)
Adenocarcinoma - Mortality
(5)
Intensity-Modulated Radiation Therapy
(5)
Neoadjuvant Chemoradiotherapy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prognosis of three histological subtypes of colorectal adenocarcinoma: A retrospective analysis of 8005 Chinese patients

MicroRNA-223 Enhances Radiation Sensitivity of U87MG Cells In Vitro and In Vivo by Targeting Ataxia Telangiectasia Mutated

An expansion study of genotype-driven weekly irinotecan and capecitabine in combination with neoadjuvant radiotherapy for locally advanced rectal cancer with UGT1A1 11 genotype

Long-course neoadjuvant chemoradiotherapy with versus without a concomitant boost in locally advanced rectal cancer: a randomized, multicenter, phase II trial (FDRT-002)

Risk factors of synchronous inguinal lymph nodes metastasis for lower rectal cancer involving the anal canal

A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma

Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients

Genotype-driven phase I study of weekly irinotecan in combination with capecitabine-based neoadjuvant chemoradiation for locally advanced rectal cancer

Phase II clinical trial of advanced and metastatic gastric cancer based on continuous infusion of 5-fluorouracil combined with epirubicin and oxaliplatin

Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study

Unfavorable effect of small tumor size on cause-specific survival in stage IIA colon cancer, a SEER-based study

CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer

Integrated Analysis of Transcriptomic and Proteomics Data Reveals the Induction Effects of Rotenoid Biosynthesis of Mirabilis himalaica Caused by UV-B Radiation

circCPA4 induces malignant behaviors of prostate cancer via miR-491-5p/SHOC2 feedback loop

Efficacy and Safety of Tamsulosin in Medical Expulsive Therapy for Distal Ureteral Stones with Renal Colic: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial

Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation

Suchergebnisse filtern